Inventor · disambiguated record
Benjamin Katchman
Also filed as: KATCHMAN BENJAMIN · KATCHMAN BENJAMIN A · KATCHMAN BENJAMIN ALAN
12 granted patents·14 pending applications·13 citations·filing 2013–2024
85Inventor score
Files withUNIV ARIZONA STATE6ECCRINE SYSTEMS INC4HOGAN MICHAEL EDWARD4Eggers Frederick Henry2UNIV ARIZONA2
Top patents by PatentIndex Score
26 records- 0186US9546370B2QSOX1 as an anti-neoplastic drug targetARIZONA BOARD OF REGENTS A BODY CORP OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STA·Filed 2015·Granted Jan 17, 2017·3 cites·14 claims
- 0285US11243208B2Autoantibody biomarkers for the early detection of ovarian cancerUNIV ARIZONA STATE·Filed 2017·Granted Feb 8, 2022·2 cites·3 claims
- 0384US2025271437A1Autoantibody biomarkers for the early detection of ovarian cancerUNIV ARIZONA STATE·Filed 2024·Application pending·0 cites
- 0482US12098434B2Methods for detecting low levels of COVID-19 virusHOGAN MICHAEL EDWARD·Filed 2020·Granted Sep 24, 2024·1 cites·16 claims
- 0581US10591474B2Point-of-care fluorescent immunoassay for identifying biomarkers in patient biofluid samplesUNIV ARIZONA STATE·Filed 2016·Granted Mar 17, 2020·2 cites·14 claims
- 0681US8946186B2QSOX1 as an anti-neoplastic drug targetUNIV ARIZONA·Filed 2013·Granted Feb 3, 2015·3 cites·28 claims
- 0780US11702709B2Combinatorial microarray assay for clade variant detectionEggers Frederick Henry·Filed 2021·Granted Jul 18, 2023·1 cites·13 claims
- 0879US11920188B2Combinatorial microarray assay for clade variant detectionEggers Frederick Henry·Filed 2021·Granted Mar 5, 2024·1 cites·10 claims
- 0976US12196757B2Autoantibody biomarkers for the early detection of ovarian cancerUNIV ARIZONA STATE·Filed 2021·Granted Jan 14, 2025·0 cites·7 claims
- 1067US2025092470A1Methods for Detecting and Discriminating among Microbes in Microbial Pathogen MixturesPathogenDX Inc·Filed 2024·Application pending·0 cites
- 1166US2018185477A1Qsox1 as an anti-neoplastic drug targetYEDA RES & DEV·Filed 2018·Application pending·0 cites
- 1264US2017182158A1Qsox1 as an anti-neoplastic drug targetYEDA RES & DEV·Filed 2016·Application pending·0 cites
- 1361US2020191782A1Point-of-Care Fluorescent Immunoassay for Identifying Biomarkers in Patient Biofluid SamplesUNIV ARIZONA STATE·Filed 2020·Application pending·0 cites
- 1458US11618917B2Methods for microbial DNA analysisHOGAN MICHAEL EDWARD·Filed 2022·Granted Apr 4, 2023·0 cites·12 claims
- 1558US2016122765A1Qsox1 as an anti-neoplastic drug targetUNIV ARIZONA·Filed 2015·Application pending·0 cites
- 1657US2014141015A1QSOX1 as an Anti-Neoplastic Drug TargetLAKE DOUGLAS·Filed 2014·Application pending·0 cites
- 1756US2022267829A1Combinatorial Microarray Assay for Detecting and Genotyping SARS-CoV-2UNIV MARYLAND·Filed 2022·Application pending·0 cites
- 1854US2021317540A1Microarray-Based Multiplex Fungal Pathogen AnalysisMAY MELISSA·Filed 2021·Application pending·0 cites
- 1953US2022364157A1Methods for Detecting Low Levels of Covid-19 VirusHOGAN MICHAEL EDWARD·Filed 2020·Application pending·0 cites
- 2049US11319582B2Methods for microbial DNA analysisHOGAN MICHAEL EDWARD·Filed 2020·Granted May 3, 2022·0 cites·14 claims
- 2142US11543407B2Flexible optical biosensor for point of use multi-pathogen detectionUNIV ARIZONA STATE·Filed 2015·Granted Jan 3, 2023·0 cites·9 claims
- 2240US2020077936A1Sweat sensing device kidney biomarker measurementECCRINE SYSTEMS INC·Filed 2017·Application pending·0 cites
- 2339US2020080987A1Biofluid sensing device cytokine measurementECCRINE SYSTEMS INC·Filed 2017·Application pending·0 cites
- 2437US2019183394A1Biosensor disease and infection screeningECCRINE SYSTEMS INC·Filed 2017·Application pending·0 cites
- 2537US2019117132A1Biofluid sensing device nucleotide sensing applicationsECCRINE SYSTEMS INC·Filed 2017·Application pending·0 cites
- 2636US11832801B2Sweat as a biofluid for analysis and disease identificationCARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIV·Filed 2017·Granted Dec 5, 2023·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →